Inherited cardiomyopathies caused by troponin mutations

Journal of Geriatric Cardiology

Volumn 10, Issue 1, 2013, Pages 91-101

  Lu, Qun Wei ^a   Wu, Xiao Yan ^a   Morimoto, Sachio ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Calcium sensitivity; Cardiomyopathy; Muscle contraction; Troponin

Indexed keywords

CALCIUM ION;

CONGESTIVE CARDIOMYOPATHY; GENE; GENE MUTATION; HEART CONTRACTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INHERITED HYPERTROPHIC CARDIOMYOPATHY; MYOFILAMENT; NONHUMAN; RESTRICTIVE CARDIOMYOPATHY; REVIEW; TROPONIN C GENE; TROPONIN I GENE; TROPONIN T GENE;

EID: 84878956600     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.01.014     Document Type: Review

References (118)

1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996; 93: 841-842. (Pubitemid 26074816)
2. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 2008; 77: 659-666. (Pubitemid 351301864)
3. Seidman CE, Seidman JG. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res 2011; 108: 743-750.
4. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564-1575. (Pubitemid 24366905)
5. Rivenes SM, Kearney DL, Smith EO, et al. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000; 102: 876-882.
6. Siegel RJ, Shah PK, Fishbein MC. Idiopathic restrictive cardiomyopathy. Circulation 1984; 70: 165-169. (Pubitemid 14053037)
7. Hamilton RM. Arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol 2009; 32 Suppl 2: S44-S51.
8. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 1990; 62: 999-1006.
9. Poetter K, Jiang H, Hassanzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996; 13: 63-69. (Pubitemid 26139295)
10. Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995; 11: 438-440.
11. Satoh M, Takahashi M, Sakamoto T, et al. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun 1999; 262: 411-417. (Pubitemid 29429882)
12. Mogensen J, Klausen IC, Pedersen AK, et al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 1999; 103: R39-R43. (Pubitemid 29535504)
13. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332: 1058-1064.
14. Thierfelder L, Watkins H, MacRae C, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77: 701-712.
15. Kimura A, Harada H, Park JE, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379-382. (Pubitemid 27323305)
16. Olson TM, Michels VV, Thibodeau SN, et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998; 280: 750-752. (Pubitemid 28243352)
17. Towbin JA, Hejtmancik JF, Brink P, et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993; 87: 1854-1865. (Pubitemid 23165627)
18. Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999; 100: 461-464. (Pubitemid 29360152)
19. Sakamoto A, Ono K, Abe M, et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 1997; 94: 13873-13878. (Pubitemid 28009677)
20. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000; 106: 655-662.
21. McNally E, MacLeod H, Dellefave L. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy, Autosomal Dominant. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online), 2008; initial posting, 2005. Available at: http://www.genetests.org.
22. Moric-Janiszewska E, Markiewicz-Loskot G. Review on the genetics of arrhythmogenic right ventricular dysplasia. Europace 2007; 9: 259-266. (Pubitemid 47079239)
23. Ebashi S. Third Component Participating in the Superprecipitation of 'Natural Actomyosin'. Nature 1963; 200: 1010.
24. Ebashi S, Ebashi F. A New Protein Component Participating in the Superprecipitation of Myosin B. J Biochem 1964; 55: 604-613.
25. Craig R, Lehman W. Crossbridge and tropomyosin positions observed in native, interacting thick and thin filaments. J Mol Biol 2001; 311: 1027-1036. (Pubitemid 32803718)
26. Solaro RJ, Van Eyk J. Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 1996; 28: 217-230. (Pubitemid 26110467)
27. Farah CS, Reinach FC. The troponin complex and regulation of muscle contraction. FASEB J 1995; 9: 755-767.
28. Ohtsuki I, Morimoto S. Troponin: regulatory function and disorders. Biochem Biophys Res Commun 2008; 369: 62-73.
29. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 2000; 87: 275-281. (Pubitemid 30655967)
30. Geeves MA, Holmes KC. The molecular mechanism of muscle contraction. Adv Protein Chem 2005; 71: 161-93. (Pubitemid 41446929)
31. Geeves MA, Holmes KC. Structural mechanism of muscle contraction. Annu Rev Biochem 1999; 68: 687-728. (Pubitemid 29449207)
32. Solaro RJ. Sarcomere control mechanisms and the dynamics of the cardiac cycle. J Biomed Biotechnol 2010; 2010: 105648.
33. Ohtsuki I. Molecular arrangement of troponin-T in the thin filament. J Biochem 1979; 86: 491-497. (Pubitemid 10251093)
34. Kobayashi T, Solaro RJ. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol 2005 67: 39-67. (Pubitemid 40404485)
35. Tanokura M, Tawada Y, Onoyama Y, et al. Primary structure of chymotryptic subfragments from rabbit skeletal troponin T. J Biochem 1981; 90: 263-265. (Pubitemid 11063129)
36. Tanokura M, Tawada Y, Ono A, et al. Chymotryptic subfragments of troponin T from rabbit skeletal muscle. Interaction with tropomyosin, troponin I and troponin C. J Biochem 1983; 93: 331-337. (Pubitemid 13073939)
37. 2+ sensitivity of superprecipitation and ATPase activities of actomyosin. J Biochem 1981; 90: 259-261.
38. Kobayashi T, Jin L, de Tombe PP. Cardiac thin filament regulation. Pflugers Arch 2008; 457: 37-46.
39. Franklin AJ, Baxley T, Kobayashi T, et al. The C-terminus of troponin T is essential for maintaining the inactive state of regulated actin. Biophys J 2012; 102: 2536-2544.
40. Gomes AV, Guzman G, Zhao J, et al. Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J Biol Chem 2002; 277: 35341-35349.
41. VanBuren P, Alix SL, Gorga JA, et al. Cardiac troponin T isoforms demonstrate similar effects on mechanical performance in a regulated contractile system. Am J Physiol Heart Circ Physiol 2002; 282: H1665-H1671. (Pubitemid 34654833)
42. Sumandea MP, Pyle WG, Kobayashi T, et al. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 2003; 278: 35135-35144. (Pubitemid 37102277)
43. Otsuka H, Arimura T, Abe T, et al. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J 2012; 76: 453-461.
44. 2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am J Physiol Heart Circ Physiol 2001; 280: H705-713.
45. Pasquale F, Syrris P, Kaski JP, et al. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene. Circ Cardiovasc Genet 2012; 5: 10-17.
46. Szczesna D, Zhang R, Zhao J, et al. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem 2000; 275: 624-630. (Pubitemid 30039027)
47. Miller T, Szczesna D, Housmans PR, et al. Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation. J Biol Chem 2001; 276: 3743-3755.
48. Knollmann BC, Blatt SA, Horton K, et al. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy. J Biol Chem 2001; 276: 10039-10048.
49. Knollmann BC, Potter JD. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. Trends Cardiovasc Med 2001; 11: 206-212. (Pubitemid 32946869)
50. Harada K, Potter JD. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction. J Biol Chem 2004; 279: 14488-14495. (Pubitemid 38618835)
51. Tardiff JC. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes. Heart Fail Rev 2005; 10: 237-248. (Pubitemid 43115833)
52. 2+ regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein. Circ Res 2000; 86: 1146-1152.
53. Manning EP, Guinto PJ, Tardiff JC. Correlation of molecular and functional effects of mutations in cardiac troponin T linked to familial hypertrophic cardiomyopathy: an integrative in silico/in vitro approach. J Biol Chem 2012; 287: 14515-14523.
54. Hatakenaka M, Ohtsuki I. Replacement of three troponin components with cardiac troponin components within single glycerinated skeletal muscle fibers. Biochem Biophys Res Commun 1991; 181: 1022-1027.
55. 2+-activated tension development of single glycerinated rabbit skeletal muscle fibers. Eur J Biochem 1992; 205: 985-993.
56. Morimoto S, Nakaura H, Yanaga F, et al. Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T. Biochem Biophys Res Commun 1999; 261: 79-82. (Pubitemid 29371621)
57. Nakaura H, Yanaga F, Ohtsuki I, et al. Effects of missense mutations Phe110Ile and Glu244Asp in human cardiac troponin T on force generation in skinned cardiac muscle fibers. J Biochem 1999; 126: 457-460. (Pubitemid 29452608)
58. Harada K, Takahashi-Yanaga F, Minakami R, et al. Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T. J Biochem 2000; 127: 263-268. (Pubitemid 30136909)
59. Takahashi-Yanaga F, Ohtsuki I, Morimoto S. Effects of troponin T mutations in familial hypertrophic cardiomyopathy on regulatory functions of other troponin subunits. J Biochem 2001; 130: 127-131. (Pubitemid 32674573)
60. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 1999; 274: 8806-8812.
61. 2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol 1998; 275: C200-C207.
62. Palm T, Graboski S, Hitchcock-DeGregori SE, et al. Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region. Biophys J 2001; 81: 2827-2837. (Pubitemid 33020068)
63. Manning EP, Tardiff JC, Schwartz SD. Molecular effects of familial hypertrophic cardiomyopathy-related mutations in the TNT1 domain of cTnT. J Mol Biol 2012; 421: 54-66.
64. Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343: 1688-1696.
65. 2+-desensitizing effect of a deletion mutation DK210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proc Natl Acad Sci USA 2002; 99: 913-918.
66. Robinson P, Mirza M, Knott A, et al. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J Biol Chem 2002; 277: 40710-40716. (Pubitemid 35215653)
67. Venkatraman G, Harada K, Gomes AV, et al. Different functional properties of troponin T mutants that cause dilated cardiomyopathy. J Biol Chem 2003; 278: 41670-41676. (Pubitemid 37310424)
68. Mirza M, Marston S, Willott R, et al. Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J Biol Chem 2005; 280: 28498-28506. (Pubitemid 41105750)
69. Lu QW, Morimoto S, Harada K, et al. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization. J Mol Cell Cardiol 2003; 35: 1421-1427. (Pubitemid 37491185)
70. Willott RH, Gomes AV, Chang AN, et al. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? J Mol Cell Cardiol 2010; 48: 882-892.
71. Peddy SB, Vricella LA, Crosson JE, et al. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics 2006; 117: 1830-1833. (Pubitemid 46071419)
72. Kaski JP, Syrris P, Burch M, et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart 2008; 94: 1478-1484.
73. 2+ sensitivity of force development and impairs the inhibitory properties of troponin. J Biol Chem 2008; 283: 2156-2166.
74. 2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach. J Biol Chem 2011; 286: 20901-20912.
75. Zhou X, Morris EP, Lehrer SS. Binding of troponin I and the troponin I-troponin C complex to actin-tropomyosin. Dissociation by myosin subfragment 1. Biochemistry 2000; 39: 1128-1132. (Pubitemid 30075342)
76. Ohtsuki I, Shiraishi F. Periodic binding of troponin C.I and troponin I to tropomyosin-actin filaments. J Biochem 2002; 131: 739-743. (Pubitemid 34535043)
77. Solaro RJ, Rosevear P, Kobayashi T. The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun 2008; 369: 82-87.
78. Baryshnikova OK, Li MX, Sykes BD. Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies. J Mol Biol 2008; 375: 735-751. (Pubitemid 350297284)
79. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res 2004; 94: 146-158. (Pubitemid 38197446)
80. Saeki Y, Shiozawa K, Yanagisawa K, et al. Adrenaline increases the rate of cross-bridge cycling in rat cardiac muscle. J Mol Cell Cardiol 1990; 22: 453-460. (Pubitemid 20195704)
81. Zhang R, Zhao J, Mandveno A, et al. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 1995; 76: 1028-1035.
82. 2+ affinity of cardiac troponin C. J Biol Chem 1995; 270: 30773-30780.
83. Kentish JC, McCloskey DT, Layland J, et al. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 2001; 88: 1059-1065. (Pubitemid 34137119)
84. Burkart EM, Sumandea MP, Kobayashi T, et al. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 2003; 278: 11265-11272. (Pubitemid 36792683)
85. Pyle WG, Sumandea MP, Solaro RJ, et al. Troponin I serines 43/45 and regulation of cardiac myofilament function. Am J Physiol Heart Circ Physiol 2002; 283: H1215-H1224.
86. Lu QW, Hinken AC, Patrick SE, et al. Phosphorylation of cardiac troponin I at protein kinase C site threonine 144 depresses cooperative activation of thin filaments. J Biol Chem 2010; 285: 11810-11817.
87. Albury AN, Swindle N, Swartz DR, et al. Effect of hypertrophic cardiomyopathy-linked troponin C mutations on the response of reconstituted thin filaments to calcium upon troponin I phosphorylation. Biochemistry 2012; 51: 3614-3621.
88. Wang Y, Pinto JR, Solis RS, et al. Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy. J Biol Chem 2012; 287: 2156-2167.
89. Biesiadecki BJ, Kobayashi T, Walker JS, et al. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res 2007; 100: 1486-1493. (Pubitemid 46834761)
90. Marston SB. How do mutations in contractile proteins cause the primary familial cardiomyopathies? J Cardiovasc Transl Res 2011; 4: 245-255.
91. Carballo S, Robinson P, Otway R, et al. Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res 2009; 105: 375-382.
92. Takahashi-Yanaga F, Morimoto S, Harada K, et al. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001; 33: 2095-2107. (Pubitemid 34073053)
93. 2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem 2006; 281: 13471-13477.
94. Murphy RT, Mogensen J, Shaw A, et al. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 2004; 363: 371-372. (Pubitemid 38169547)
95. Howarth JW, Meller J, Solaro RJ, et al. Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin. J Mol Biol 2007; 373: 706-722. (Pubitemid 47488403)
96. Murakami C, Nakamura S, Kobayashi M, et al. Analysis of the sarcomere protein gene mutation on cardiomyopathy - Mutations in the cardiac troponin I gene. Leg Med 2010; 12: 280-283.
97. Mogensen J, Kubo T, Duque M, et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest 2003; 111: 209-216. (Pubitemid 36105919)
98. 2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. Biochem Biophys Res Commun 2005; 338: 1519-1526.
99. Sundaralingam M, Bergstrom R, Strasburg G, et al. Molecular structure of troponin C from chicken skeletal muscle at 3-angstrom resolution. Science 1985; 227: 945-948. (Pubitemid 15090458)
100. 2+-saturated form. 2003; 424: 35-41.
101. Landstrom AP, Parvatiyar MS, Pinto JR, et al. Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J Mol Cell Cardiol 2008; 45: 281-288.
102. 2+ sensitivity of myofilaments containing cardiac troponin C mutations (G159D and L29Q) good predictors of the phenotypic outcomes? J Biol Chem 2008; 283: 33119-33128.
103. Parvatiyar MS, Landstrom AP, Figueiredo-Freitas C, et al. A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation. J Biol Chem 2012; 287: 31845-31855.
104. Mogensen J, Murphy RT, Shaw T, et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004; 44: 2033-2040. (Pubitemid 39473290)
105. Lim CC, Yang H, Yang M, et al. A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys J 2008; 94: 3577-3589.
106. Pinto JR, Siegfried JD, Parvatiyar MS, et al. Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy. J Biol Chem 2011; 286: 34404-34412.
107. Du CK, Morimoto S, Nishii K, et al. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 2007; 101: 185-194. (Pubitemid 47196586)
108. Hanson EL, Jakobs PM, Keegan H, et al. Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy. J Card Fail 2002; 8: 28-32. (Pubitemid 34163847)
109. Hernandez OM, Szczesna-Cordary D, Knollmann BC, et al. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers. J Biol Chem 2005; 280: 37183-37194. (Pubitemid 41587803)
110. Gomes AV, Potter JD. Molecular and cellular aspects of troponin cardiomyopathies. Ann N Y Acad Sci 2004; 1015: 214-224. (Pubitemid 38879492)
111. Chang AN, Parvatiyar MS, Potter JD. Troponin and cardiomyopathy. Biochem Biophys Res Commun 2008; 369: 74-81.
112. 2+-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. J Mol Cell Cardiol 2005; 39: 754-765.
113. Sanbe A, James J, Tuzcu V, et al. Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Circulation 2005; 111: 2330-2338. (Pubitemid 40647069)
114. Ford SJ, Mamidi R, Jimenez J, et al. Effects of R92 mutations in mouse cardiac troponin T are influenced by changes in myosin heavy chain isoform. J Mol Cell Cardiol 2012; 53: 542-551.
115. Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopathies. N Engl J Med 2011; 364: 1643-1656.
116. Chalovich JM. Disease causing mutations of troponin alter regulated actin state distributions. J Muscle Res Cell Motil 2012; 33: 493-499
117. 2+ association and dissociation rates. PLoS One 2012; 7: e38259.
118. Schober T, Huke S, Venkataraman R, et al. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia Circ Res 2012; 111: 170-179.